Citations

Clear

4206 citation(s) found for "Chen, B".

Longitudinal Surgical Modeling of Early Glioblastoma Recurrence Reveals Emergence of Margin-Associated Neural Programs
Malla, Adarsha P. , Flick, Matthew , Fang, Jennifer R. , Fan, Xiaoxuan , Chen, Chixiang , Beniwal, Angad , Sereduk, Chris , Drexler, Richard , Poulopoulos, Alexandros , Monje, Michelle , Anastasiadis, Pavlos , Tran, Nhan L. , Winkles, Jeffrey A.

Mayo Clinic

Cancer Research | October 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: OF1-OF20

10.1158/0008-5472.can-25-5176 | PMID 42831833 Get It

Abstract Glioblastoma (GBM) is a lethal, treatment-resistant brain cancer characterized by diffuse brain invasion, complex neuron–glioma signaling, and cellular, molecular, and spatial heterogeneity. Surgery is the current mainstay of treatment, aimed at maximizing tumor cytoreduction, decompressing the brain to improve neurologic function and providing material for analyses to inform prognostication and adjuvant treatment selection. To accurately model GBM surgical resection and tissue sampling in preclinical animal models, we developed the Maximal Safe Intracranial Surgery (MSIS) platform. MSIS integrated a miniaturized neurosurgical resection device and enabled a safe, tunable, and reproducible approach for intracranial tumor resection, multiregional biopsy, and longitudinal tissue sampling in murine models, with stereotactic, sterile, and high-viability tissue collection. MSIS was applied across five distinct orthotopic brain tumor models to reproducibly generate histologically and radiologically representative models of postsurgical GBM. Similar to humans, increasing the extent of resection correlated with improved animal survival, and recurrent growth patterns varied significantly by model type. Transcriptional profiles of matched primary versus postsurgical recurrent tumors revealed enrichment of margin-associated transcriptional states consistent with neuron–glioma signaling. Overall, the MSIS approach offers opportunities to model the standard of care, dissect the spatial and temporal dynamics of GBM, and pair therapeutic discovery with contextual tumor pathobiology. Significance: A clinically derived stereotactic resection platform models surgical resection in glioblastoma, enabling longitudinal tissue sampling and revealing conserved early-recurrence neuron-glioma programs in patient-derived models.
Prospective patient preference study for chronic lymphocytic leukemia (CLL) treatment attributes impacting patient shared decision-making
Ailawadhi, Sikander, Challagulla, Swetha, Meng, Yan, Totev, Todor , Pilon, Dominic, Diaz, Lilian, Chen, Zhuo, Yang, Keri, Ailawadhi, Sikander , Pilon, Dominic , Chen, Zhuo, Yang, Keri

Mayo Clinic

Expert Review of Anticancer Therapy | September 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-9

10.1080/14737140.2026.2722166 | PMID 42766011 Get It

Widespread Loss of Heterozygosity and Endoreduplication in Odontogenic Myxoma
Stojanov, Ivan J. , Dababneh, Melad N., Cracolici, Vincent, Qureshi, Sana, Hattery, Travis , Chen, Mark , Smith, Benjamin F. , O’Neill, Diane, Wolbert, Matthew, Schneider, Keith M., Shurtleff, Sheila, Astbury, Caroline , Geiersbach, Katherine B. , Woo, Sook-Bin, Fritchie, Karen, Weber, Grace E. , Dermawan, Josephine K., Dababneh, Melad , Cracolici, Vincent , O'Neill, Diane H., Schneider, Keith M., Shurtleff, Sheila A., Woo, Sook‐Bin , Fritchie, Karen, Dermawan, Josephine K.

Mayo Clinic

American Journal of Surgical Pathology | September 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/pas.0000000000002616 | PMID 42745350 Get It

Odontogenic myxoma (OM) is an uncommon, locally aggressive odontogenic neoplasm with characteristic histologic and clinico-radiographic features but with potential for histologic overlap with other odontogenic and non-odontogenic entities and a non-specific immunoprofile. Widespread loss of heterozygosity (LOH) has been recently described in rare cases of OM. The aim of this study was to determine whether widespread LOH represents a recurrent molecular signature that can be leveraged for clinical decision-making. Allele-specific copy number variation data from chromosomal microarray were generated from 7 OM, comprising a combined prospective and retrospective cohort. Four tumors arose in the mandible and 3 in the maxilla in patients ranging in age from 18 to 94 years (median: 44), with tumor size ranging from 2.2 to 13.0 cm. Variable amounts of fibrous stroma (odontogenic “fibromyxoma”) were present in 4/7 OM, and hypercellularity not typically appreciated in conventional OM was present in 3/7 cases. All OM (7/7) demonstrated widespread LOH, with 5 cases showing a near-haploid/low hypodiploid genomes (multiple monosomies) and 2 cases showing evidence of pseudo-hyperdiploidy due to probable endoreduplication. Both pseudo-hyperdiploid cases were ≥10 cm in size; 1 represented local recurrence. Chromosomes 1 to 3, 6, 9, 11, 13, 15, and 22 demonstrated LOH in ≥75% of cases (chromosomes 1 to 3, 6, and 9 in 100% of cases), while chromosomes 5, 12, 19, and 20 universally retained heterozygosity. Altogether, widespread LOH is a recurrent event in OM and a novel finding in odontogenic pathology, and allele-specific copy number variation analysis can serve as a diagnostic adjunct in challenging cases.
LSD1-mediated demethylation of the DNA damage response factor ATM promotes senescence and organ aging
Zhang, Yingying, Chen, Yu , Zhang, Xiaoqin , Li, Xiaoyan , Cheng, Alice, Li, Xiaogang , Li, Linda Xiaoyan , Cheng, Alice Shasha

Mayo Clinic

Journal of Clinical Investigation | September 14, 2026 | Volume: 136 | Issue: 18 | Pages: No page available

10.1172/jci199854 | PMID 42741942 Get It

Aging occurs heterogeneously across organs, leading to progressive tissue dysfunction. Cellular senescence is a stress response triggered by age-associated insults, yet the mechanisms regulating senescence and organ aging remain incompletely understood. Here, we defined a role for lysine-specific demethylase 1 (LSD1) in DNA damage–mediated senescence and organ aging. LSD1 was upregulated in aged organs and senescent cells. In response to natural aging or ionizing radiation–induced DNA damage, LSD1 interacted with and demethylated ATM at lysine 3,016, as confirmed using a newly generated ATM-K3016me antibody. This modification sustained ATM phosphorylation, amplified DNA damage signaling, and delayed checkpoint recovery, promoting senescence and organ aging. Inhibition of LSD1 accelerated ATM dephosphorylation via WIP1, enhanced DNA repair, reduced senescence and DNA damage, and prevented irradiation-induced hair graying. Elimination of senescent cells with senolytics reduced LSD1 protein in aged organs, indicating a feedback loop between LSD1 and senescence. Mechanistically, LSD1 underwent autophagosome-lysosome degradation through interaction with LC3 and Beclin1, and autophagy impairment during DNA damage contributed to LSD1 accumulation in senescent cells. This study revealed LSD1 as a key regulator of DNA damage–induced senescence and organ aging and suggested that targeting LSD1 may attenuate senescence, delay organ aging, and prevent hair graying.
CDK4/6 Inhibitor Abemaciclib Arrests and Reverses Kidney Cyst Progression in Preclinical Models of Autosomal Dominant Polycystic Kidney Disease
Cao, Yingshu , Sun, Xiaobo , Huang, Yan , Ji, Biyun , Chen, Renee , Li, Yuan , Liang, Yan , Aghevli, Ariana, Patel, Vishal , Harris, Peter C. , Ling, Kun , Hu, Jinghua , Chen, Chuan , Ji, Biyun , Chen, Renee , Liang, Yan , Yang, Nicole, Patel, Vishal , Harris, Peter C , Ling, Kun , He, Kai , Chen, Chuan , Yang, Nicole, He, Kai

Mayo Clinic

Journal of the American Society of Nephrology | September 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1681/asn.0000001269 | PMID 42735034 Get It

Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited disorder leading to kidney failure. Tolvaptan, the only FDA-approved therapy, modestly slows disease progression but is limited by significant adverse effects, highlighting the need for more effective and better-tolerated treatments. Ciliary polycystins are central to ADPKD pathogenesis. We previously demonstrated that a cilia base-localized pool of CDK6 restricts ciliary polycystin abundance by suppressing axonemal polyglutamylation. However, whether CDK6 inhibition can restore polycystin function and suppress ADPKD progression in vivo remains unknown. Methods: Abemaciclib was tested in in vitro 3D cyst assays and ex vivo metanephric organ cultures. In vivo efficacy of early- and late-stage intervention were assessed in F1(129/B6) Pkd1 R3277C/R3277C mice receiving daily abemaciclib. Tolvaptan served as a therapeutic control. Cyst burden, fibrosis in the kidneys, kidney function, and primary cilia of renal epithelial cells were analyzed at study endpoints. Results: CDK6 was prominently upregulated in cyst-lining cells in human and murine PKD kidneys. At doses substantially lower than those used in oncology, abemaciclib robustly suppressed cyst growth in vitro and ex vivo . In vivo , long-term early treatment arrested cyst progression more effectively than tolvaptan without detectable toxicity. Late intervention largely halted cyst growth in females and reversed cyst progression in males. Mechanistically, abemaciclib restored axonemal polyglutamylation and increased ciliary polycystin levels. Conclusions: Abemaciclib has greater therapeutic efficacy and tolerability than tolvaptan in this preclinical model, largely driven by CDK6 inhibition–mediated restoration of axonemal polyglutamylation and increased ciliary polycystin abundance.
Cardiac Resynchronization Therapy and Circulating Metabolomic Profile in Patients With Advanced Heart Failure
Qian, Zhiyong , Lee, Hon-Chi , Mulpuru, Siva K. , Vučković, Ivan , Deshmukh, Abhishek , DeSimone, Christopher V. , Asirvatham, Samuel J. , Wen, Songnan, Li, Chuanwei , Zhang, Song , Dasari, Surendra, Dzeja, Petras P. , Yu, Bing , Bailey, Kent R. , Chen, Horng H. , Cha, Yong‐Mei , Deshmukh, Abhishek J , Lanza, Ian R , Yu, Bing , Bailey, Kent R , Chen, Horng , Cha, Yong-Mei , Asirvatham, Samuel J , DeSimone, Christopher V , Vuckovic, Ivan , Zhang, Song , Dasari, Surendra, Lanza, Ian R.

Mayo Clinic

Circulation: Heart Failure | September 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/circheartfailure.125.014148 | PMID 42717876 Get It

BACKGROUND: It is unknown whether cardiac resynchronization therapy (CRT) improves systemic metabolomic profile by enhancing left ventricular function. The observational cohort study aimed to investigate the effect of CRT on left ventricular ejection fraction (LVEF) and circulating plasma metabolites in patients who had heart failure with reduced LVEF. METHODS: We prospectively screened patients with ischemic cardiomyopathy and nonischemic cardiomyopathy who received CRT with a defibrillator for LVEF ≤35% according to current guidelines. Clinical assessment included echocardiography and device interrogation. Blood samples for metabolomic analysis were collected before CRT and at 6-month follow-up. Plasma was subjected to gas chromatography-mass spectrometry and 1 H nuclear magnetic resonance-based metabolomic analysis. RESULTS: Totally 92 patients were enrolled, with a mean age of 67.3±11.3 years (37.0% female). LVEF was significantly improved from 28.9±7.6% at baseline to 36.0±11.3% at 6 months ( P <0.001) and to 40.1±12.6% at 12 months ( P <0.001). After CRT, 42 metabolite features were significantly decreased compared with the baseline. The ketone bodies, including 3-hydroxybutyrate ( P <0.001) and acetone ( P =0.01), were reduced. A branched-chain amino acid, isoleucine, was also decreased after CRT ( P =0.01). These metabolomic changes were mainly observed in the nonischemic cardiomyopathy group, while the metabolomic profile in the ischemic cardiomyopathy group was characterized by enhanced amino acid oxidation and elevated levels of lactate and pyruvate. The improvement in LVEF positively correlated with the ratio of changes in ketone bodies and isoleucine. CONCLUSIONS: CRT may modulate the systemic plasma metabolomic profile, which correlated with improvement in left ventricular function in patients with severe heart failure with reduced ejection fraction.
Beyond Binary PTEN Loss: Integrating Genomics, Long-Term Outcomes, and AI-Assisted Digital Pathology to Define Actionable PTEN Deficiency in Prostate Cancer.
Zarka, Jabra, Pessoa, Rodrigo Rodrigues , Gupta, Sounak , Chen, Eric, Greipp, Patricia, Orme, Jacob J., Karnes, R. Jeffrey, Cheville, John C. , Heath, Elisabeth, Zarka, Jabra , Greipp, Patricia T. , Childs, Daniel S. , Orme, Jacob J. , Karnes, R. Jeffrey

Mayo Clinic

International Journal of Cancer Care and Delivery | September 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.53876/001a.129758 Get It

Benchmarking four commercial antimicrobial susceptibility testing systems and disk diffusion to reference broth microdilution in the assessment of gram-negative bacterial isolates
Rhoads, Daniel D. , Sherman, Jingzi , Baker, Kristin, Culbreath, Karissa , McElvania, Erin , Harrington, Amanda, Streva, Vincent , Marino, Jamie , Westblade, Lars F. , Stern, Eric J. , Simner, Patricia J. , Culbreath, Karissa , McElvania, Erin , Streva, Vincent , Marino, Jamie , Westblade, Lars F , Stern, Eric , Simner, Patricia J , Rhoads, Daniel D , Chen, Felicia , Harrington, Amanda

Mayo Clinic

Journal of Clinical Microbiology | September 9, 2026 | Volume: 64 | Issue: 10 | Pages: No page available

10.1128/jcm.00502-26 | PMID 42714132 Get It

ABSTRACT Commercial antimicrobial susceptibility testing (AST) systems for gram-negative bacteria provide operational advantages over reference broth microdilution (BMD) testing, but the results produced by commercial AST systems might not be as accurate as the reference method. Assessing and comparing the performance of AST systems can be informative for clinical microbiology practice. In total, 280 clinical isolates and 100 isolates from the U.S. Centers for Disease Control and Prevention Antimicrobial Resistance Isolate Bank, including Enterobacterales and Pseudomonas aeruginosa, were intended to be tested using disk diffusion (DD) and automated commercial AST systems, such as Selux AST System (Selux Diagnostics), MicroScan (Beckman Coulter), Phoenix (Becton, Dickinson and Company), and Vitek 2 (bioMérieux). These results were compared to BMD as the reference standard. In total, 372 isolates were assessed. For Enterobacterales, the greatest frequency of very major errors was identified with cefepime by Vitek 2 (29.0%) and ertapenem by DD (9.1%); essential agreement less than 90% was identified with the following combinations: aztreonam by MicroScan (86.4%), aztreonam by Vitek 2 (88.9%), cefepime by Selux (86.3%), cefepime by Vitek 2 (76.8%), ceftazidime by Vitek 2 (89.9%), and levofloxacin by MicroScan (83.4%). For P. aeruginosa , essential agreement less than 90% was identified with the following combinations: gentamicin by Selux (87.2%), tobramycin by Selux (86.6%), and ciprofloxacin by Phoenix (88.4%). Overall, antimicrobials that had low demonstrable bias across all automated commercial AST systems included ampicillin, amoxicillin-clavulanate, ceftazidime-avibactam, ertapenem, and trimethoprim-sulfamethoxazole. Comparing commercial testing systems head-to-head against a reference standard provides insight into the strengths and weaknesses of the performance of these test systems, and these insights can subsequently inform local decisions regarding further investigations and potential operational mitigation strategies. IMPORTANCE This study assessed and compared the performance of multiple commercial antimicrobial susceptibility testing (AST) systems and disk diffusion methods. The accuracy of determining minimum inhibitory concentrations or zone diameters of antimicrobials and the associated interpretive categories were studied for 372 isolates of Enterobacterales and Pseudomonas aeruginosa . Performance of the evaluated systems revealed that multiple antimicrobial-organism combinations were below the standards typically required by regulatory agencies and clinical laboratories. These deficiencies varied across the commercial platforms and disk diffusion methods, highlighting the importance of benchmarking studies that compare the performance using identical isolates. These identified performance weaknesses may warrant further study and/or the implementation of mitigation strategies in clinical laboratory operations to prevent the reporting of errant results.
Diagnostic Performance of Pulse Pressure Variation for Predicting Fluid Responsiveness During Spine Surgery in the Prone Position: A Systematic Review and Meta-Analysis
Merchant, Kiran S., Deloso, Eric , Chen, Selby G. , Abode-Iyamah, Kingsley, Gruenbaum, Shaun E., Gruenbaum, Benjamin F. , Gruenbaum, Benjamin Fredrick , Goyal, Anshit , Merchant, Kiran S. , Chen, Selby , Abode-Iyamah, Kingsley , Jones, Philip M. , Gruenbaum, Shaun E.

Mayo Clinic

Journal of Neurosurgical Anesthesiology | September 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/ana.0000000000001160 | PMID 42696307 Get It

Background: Pulse pressure variation (PPV) is widely used to guide fluid responsiveness in mechanically ventilated patients, but its accuracy in the prone position remains uncertain. Prone positioning alters respiratory mechanics and venous return, potentially diminishing the respiratory variation in stroke volume that PPV is designed to detect. We conducted a systematic review and meta-analysis to evaluate the diagnostic accuracy of PPV for predicting fluid responsiveness during prone spine surgery. Methods: We searched MEDLINE, Embase, Scopus, and Cochrane through July 2025 for prospective studies evaluating PPV in adults undergoing prone spine surgery. Two reviewers independently screened studies, extracted data, assessed risk of bias using QUADAS-2, and pooled diagnostic performance using a bivariate random-effects model. The protocol was registered with PROSPERO (CRD420251106134). Results: Of 599 records, 34 underwent full-text review, and 10 studies (433 patients) were included. PPV thresholds ranged from 7% to 15%. Most studies were at low risk of bias except for the index test because thresholds were determined post hoc. For predicting fluid responsiveness, PPV had a pooled sensitivity of 68% (95% CI: 61%-75%) and specificity of 76% (95% CI: 65%-84%), with a summary area under the receiver operating characteristic curve of 0.72 (95% CI: 0.64-0.80). Conclusions: PPV showed only moderate diagnostic performance for predicting fluid responsiveness during prone spine surgery. Its performance may have been influenced by threshold variability, heterogeneous reference standards, fluid-challenge protocols, ventilation strategies, and positioning systems. PPV should therefore be interpreted alongside complementary dynamic assessments rather than in isolation, particularly during lung-protective ventilation.
Differential associations of individual- and neighborhood-level socioeconomic status with mortality in dementia: Findings from the Mayo Clinic Study of Aging
Lin, Jie , Vassilaki, Maria , Sauver, Jennifer St., Petersen, Ronald C., Wi, Chung Il, Juhn, Young J., Sham, Yuk , Sohn, Sunghwan , St Sauver, Jennifer, Sham, Yuk , Sauver, Jennifer L. St. , Petersen, Ronald C. , Wi, Chung‐Il , Juhn, Young J. , Chen, Jun

Mayo Clinic

Journal of Alzheimer’s Disease | September 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/13872877261482043 | PMID 42690834 Get It

Background Alzheimer's disease (AD) and related dementias are leading causes of death worldwide. While socioeconomic status (SES) is a critical determinant, its impact on mortality after diagnosis remains understudied. Objective To investigate the roles of neighborhood-level and individual-level SES in predicting mortality risk among older adults with incident dementia. Methods We analyzed data from 924 participants with incident dementia from the Mayo Clinic Study of Aging (N = 6909), a cohort with clinical follow-up visits every 15 months. We assessed mortality risk using Cox's time-varying survival regression, adjusting for time-fixed and time-varying covariates. Primary predictors were neighborhood-level SES (Area Deprivation Index [ADI]) and individual-level SES (housing-based SES index [HOUSES], education, and occupation). We also applied a random survival forest model to assess the predictive contribution of SES indicators and identify influential predictors. Results 857 participants (92.7%) died, with a median time from dementia diagnosis to death of 29 months (IQR: 12–54). Lower SES measured by HOUSES was associated with increased mortality risk (HR 1.28, 95% CI 1.07–1.52). Conversely, ADI, education, and occupation were not associated with mortality. Male sex, older age, congestive heart failure and diabetes were associated with higher mortality risk. In predictive analysis, HOUSES ranked among the top 10 contributors to mortality risk. Conclusions Among older adults with dementia, lower HOUSES was associated with higher mortality risk beyond neighborhood-level deprivation, education, and occupation. Integrating this housing-based individual-level SES measure into dementia care planning may help identify patients with greater socioeconomic vulnerability and inform mortality risk stratification.